Synthesis and antitumor activity of some indeno[1,2-b]quinoline-based bis carboxamides

Bioorganic and Medicinal Chemistry

Volumn 8, Issue 5, 2000, Pages 977-984

  Deady, Leslie W ^a   Desneves, José ^a   Kaye, Anthony J ^a   Finlay, Graeme J ^b   Baguley, Bruce C ^b   Denny, William A ^b  

^a LA TROBE UNIVERSITY   (Australia)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

AMIDE; BIS(11 OXO 11H INDENO[1,2 B]QUINOLINE 6 CARBOXAMIDE; DNA TOPOISOMERASE; DNA TOPOISOMERASE (ATP HYDROLYSING); IRINOTECAN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; COLON CANCER; CONTROLLED STUDY; DRUG MECHANISM; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME INHIBITION; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; IN VIVO STUDY; LEUKEMIA CELL; LEWIS CARCINOMA; MOUSE; NONHUMAN; RAT; STRUCTURE ACTIVITY RELATION;

AMIDES; ANIMALS; ANTINEOPLASTIC AGENTS; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; MICE; QUINOLINES; TUMOR CELLS, CULTURED;

ANIMALIA; RODENTIA;

EID: 0034128224     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(00)00039-0     Document Type: Article

References (26)

1. McRipley R.J., Burns-Horwitz P.E., Czerniak P.M., Diamond R.J., Diamond M.A., Miller J.L.D., Page F.J., Dexter D.L., Chen S.F. Cancer Res. 54:1994;159.
2. Houghton P.J., Cheshire P.J., Hallman J.C., Gross J.L., McRipley R.J., Sun J.H., Behrens C.H., Dexter D.L., Houghton J.A. Cancer Chemother. Pharmacol. 33:1994;265.
3. (a) LoRusso, P.; Demchik, L.; Dan, M.; Polin, L.; Gross, J. L; Corbett, T. H. Inv. New Drugs 1995, 13, 195.
4. (b) Robinson, C. P.; Robinson, K. A.; Castaner, J. Drugs Future 1996, 21, 239.
5. Brana M.F., Castellano J.M., Moran M., Perez de Vega M.J., Perron D., Conlon D., Bousquet P.F., Romerdahl C.A., Robinson S.P. Anti-Cancer Drug Design. 11:1996;297.
6. Brana M.F., Castellano J.M., Perron D., Maher C., Conlon D., Bosquet P.F., George J., Qian X.-D., Robinson S.P. J. Med. Chem. 40:1997;449.
7. Hernandez L., Cholody W.M., Hudson E.A., Resau J.H., Pauly G., Michejda C. J. Cancer Res. 55:1995;2338.
8. Cholody W.M., Hernandez L., Hassner L., Scudiero D.A., Djurickovic D.B., Michejda C.J. J. Med. Chem. 38:1995;3043.
9. (a) Chaires, J. B.; Leng, F. F.; Przewloka, T.; Fokt, I.; Ling, Y. H.; Perez-Soler, R.; Priebe, W. J. Med. Chem. 1997, 40, 261.
10. (b) Leng, F. F.; Priebe, W.; Chaires, J. B. Biochemistry, 1998, 37, 1743.
11. Gamage S.A., Spicer J.A., Atwell G.J., Finlay G.J., Baguley B.C., Denny W.A. J. Med. Chem. 42:1999;2383.
12. Spicer J.A., Gamage S.A., Atwell G.J., Finlay G.J., Baguley B.C., Denny W.A. Anti-Cancer Drug Design. 14:1999;281.
13. Spicer J.A., Gamage S.A., Atwell G.J., Finlay G.J., Baguley B.C., Denny W.A. J. Med. Chem. 40:1997;1919.
14. Deady L.W., Kaye A.J., Finlay G.J., Baguley B.C., Denny W.A. J. Med. Chem. 40:1997;2040.
15. Deady L.W., Desneves J., Kaye A.J., Thompson M., Finlay G.J., Baguley B.C., Denny W.A. Bioorg. Med. Chem. 7:1999;2801.
16. Joshua A.V., Scott J.R. Tetrahedron Lett. 25:1984;5725.
17. Braña M.F., Pérez de Vega M.J., Conlon D., Bousquet P.F., Robinson S.P. J. Het. Chem. 34:1997;807.
18. Brown H.C., Subba Rao B.C. J. Am. Chem. Soc. 82:1960;681.
19. Finlay G.J., Baguley B.C., Snow K., Judd W. J. Natl. Cancer Inst. 82:1990;662.
20. Finlay G.J., Holdaway K.M., Baguley B.C. Oncol. Res. 6:1994;33.
21. Glerrup J., Josephsen J., Michelsen K., Pedersen E., Schaffer C.E. Acta Chem. Scand. 24:1970;247.
22. Fuller, A.T.; King, H. J. Chem. Soc. 1947, 963.
23. Finlay G.J., Riou J.-F., Baguley B.C. Eur. J. Cancer. 32A:1996;708.
24. Wilkoff L.J., Dulmadge E., Chopra D.P. Proc. Soc. Exp. Biol. Med. 163:1980;233.
25. Marshall E.S., Finlay G.J., Matthews J.H.L., Shaw J.H.F., Nixon J., Baguley B.C. J. Natl. Cancer Inst. 84:1992;340.
26. Skehan P., Storeng R., Scudiero D., Monks A., McMahon J., Vistica D., Warren J.T., Bokesch H., Kenney S., Boyd M.R. J. Natl. Cancer Inst. 82:1990;1107.